Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Friday, 11 July 2025 12:00 AM EOD	Adani-Ports1430.65	Asian-Paints2439.60	Axis-Bank1173.75	Bajaj-Finance933.35	Bajaj-Finserv2016.45	Bharat-Electron409.25	Bharti-Airtel1921.90	Eternal-Ltd263.30	HCL-Technologies1637.00	HDFC-Bank1983.55	Hind-Unilever2520.10	ICICI-Bank1422.20	Infosys1594.90	ITC417.05	Kotak-Mah-Bank2219.80	Larsen-and-Toubro3540.55	M-and-M3074.95	Maruti-Suzuki12577.50	NTPC342.55	Power-Grid-Corpn298.60	Reliance-Industr1494.85	St-Bk-of-India808.50	Sun-PharmaInds1672.50	Tata-Motors681.60	Tata-Steel159.85	TCS3265.40	Tech-Mahindra1603.00	Titan-Company3358.95	Trent5352.40	UltraTech-Cem12493.75
15 mins delay SENSEX 82,500.47 [-689.81]	-11.65 -0.81%	-11.20 -0.46%	9.25 0.79%	-13.80 -1.46%	-22.65 -1.11%	-4.25 -1.03%	-43.20 -2.20%	0.50 0.19%	-26.35 -1.58%	-22.90 -1.14%	111.05 4.61%	-2.30 -0.16%	-21.85 -1.35%	0.15 0.04%	0.90 0.04%	-33.85 -0.95%	-86.80 -2.75%	-70.40 -0.56%	1.25 0.37%	-0.55 -0.18%	-22.35 -1.47%	0.50 0.06%	9.35 0.56%	-13.90 -2.00%	-0.80 -0.50%	-116.90 -3.46%	2.85 0.18%	-59.10 -1.73%	-75.85 -1.40%	-9.35 -0.07%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Gland Pharma gets GMP certificate for Telangana-based facility from Danish Medicines Agency

12-Jul-25 12:27Hrs IST

Pashamylaram is a village located in Patancheru mandal of Medak district in Telangana, India.

This certification specifically covers the facility's production of aseptically prepared powder for injection, infusion, and inhalation.

This GMP certificate is crucial for Gland Pharma as it pertains to marketing authorizations that list manufacturers located outside of the European Economic Area (EEA), allowing their products to be marketed within Denmark and potentially other EEA countries.

Gland Pharma is one of the largest and fastest-growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology, and ophthalmic solutions. The company also pioneered heparin technology in India.

The company's consolidated net profit declined 3.06% to Rs 186.54 crore as net sales fell by 7.32% to Rs 1424.91 crore in Q4 FY25 as compared with Q4 FY24.

The scrip had gained 0.89% to end at Rs 1859.05 on the BSE on Friday.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise